Srivastava PK - Search Results

1

CD8+ T Cell-Dependent Antitumor Activity In Vivo of a Mass Spectrometry-Identified Neoepitope despite Undetectable CD8+ Immunogenicity In Vitro.

Gillig MA, Brennick CA, George MM, Balsbaugh JL, Shcheglova TV, Mandoiu II, Rosales T, Baker BM, Srivastava PK, Karandikar SH. Gillig MA, et al. Among authors: srivastava pk. J Immunol. 2023 Dec 15;211(12):1783-1791. doi: 10.4049/jimmunol.2300356. J Immunol. 2023. PMID: 37966257 Free PMC article.

2

Reagent-Free and Rapid Assessment of T Cell Activation State Using Diffraction Phase Microscopy and Deep Learning.

Karandikar SH, Zhang C, Meiyappan A, Barman I, Finck C, Srivastava PK, Pandey R. Karandikar SH, et al. Among authors: srivastava pk. Anal Chem. 2019 Mar 5;91(5):3405-3411. doi: 10.1021/acs.analchem.8b04895. Epub 2019 Feb 22. Anal Chem. 2019. PMID: 30741527 Free PMC article.

3

New epitopes in ovalbumin provide insights for cancer neoepitopes.

Karandikar SH, Sidney J, Sette A, Selby MJ, Korman AJ, Srivastava PK. Karandikar SH, et al. Among authors: srivastava pk. JCI Insight. 2019 Mar 14;5(8):e127882. doi: 10.1172/jci.insight.127882. JCI Insight. 2019. PMID: 30869653 Free PMC article.

4

GeNeo: A Bioinformatics Toolbox for Genomics-Guided Neoepitope Prediction.

Al Seesi S, Al-Okaily A, Shcheglova TV, Sherafat E, Alqahtani FH, Hagymasi AT, Kaur A, Srivastava PK, Măndoiu II. Al Seesi S, et al. Among authors: srivastava pk. J Comput Biol. 2023 Apr;30(4):538-551. doi: 10.1089/cmb.2022.0491. Epub 2023 Mar 30. J Comput Biol. 2023. PMID: 36999902

5

Structural and physical features that distinguish tumor-controlling from inactive cancer neoepitopes.

Custodio JM, Ayres CM, Rosales TJ, Brambley CA, Arbuiso AG, Landau LM, Keller GLJ, Srivastava PK, Baker BM. Custodio JM, et al. Among authors: srivastava pk. Proc Natl Acad Sci U S A. 2023 Dec 19;120(51):e2312057120. doi: 10.1073/pnas.2312057120. Epub 2023 Dec 12. Proc Natl Acad Sci U S A. 2023. PMID: 38085776 Free PMC article.

6

George Klein (1925-2016) A Prescient, Luminous Voice.

Srivastava PK. Srivastava PK. Cancer Immunol Res. 2017 Apr;5(4):272. doi: 10.1158/2326-6066.CIR-17-0105. Cancer Immunol Res. 2017. PMID: 28373213 Review. No abstract available.

7

Assays to Detect Cross-Dressing by Dendritic Cells In Vivo and In Vitro.

Mohapatra AD, Srivastava PK. Mohapatra AD, et al. Among authors: srivastava pk. Methods Mol Biol. 2023;2618:251-264. doi: 10.1007/978-1-0716-2938-3_18. Methods Mol Biol. 2023. PMID: 36905522

8

Lung cDC1 and cDC2 dendritic cells priming naive CD8⁺ T cells in situ prior to migration to draining lymph nodes.

Si Y, Wang Y, Tian Q, Wang Q, Pollard JM, Srivastava PK, Esser-Kahn AP, Collier JH, Sperling AI, Chong AS. Si Y, et al. Among authors: srivastava pk. Cell Rep. 2023 Oct 31;42(10):113299. doi: 10.1016/j.celrep.2023.113299. Cell Rep. 2023. PMID: 37864794 Free PMC article.

9

Immune response to mutant neo-antigens: Cancer's lessons for aging.

Geyer RJ, Tobet R, Berlin RD, Srivastava PK. Geyer RJ, et al. Among authors: srivastava pk. Oncoimmunology. 2013 Nov 1;2(11):e26382. doi: 10.4161/onci.26382. Epub 2013 Oct 15. Oncoimmunology. 2013. PMID: 24404425 Free PMC article.

10

ERAMER: A novel in silico tool for prediction of ERAP1 enzyme trimming.

Al-Okaily A, Abu Khashabeh R, Alsmadi O, Ahmad Y, Sultan I, Tbakhi A, Srivastava PK. Al-Okaily A, et al. Among authors: srivastava pk. J Immunol Methods. 2024 Aug;531:113713. doi: 10.1016/j.jim.2024.113713. Epub 2024 Jun 24. J Immunol Methods. 2024. PMID: 38925438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

551 results

Search Page

Filters